Please login to the form below

Not currently logged in

bone cancer

This page shows the latest bone cancer news and features for those working in and with pharma, biotech and healthcare.

Lilly, Pfizer say NGF drug works in back pain too

Lilly, Pfizer say NGF drug works in back pain too

Pfizer and Lilly’s development programme for the drug includes several pivotal studies in osteoarthritis, CLBP and cancer pain due to bone metastases, with two further trials in osteoarthritis and CLBP

Latest news

More from news
Approximately 1 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Janssen granted Tracon Pharmaceuticals the rights to

  • Case study: Treatment guidance Case study: Treatment guidance

    Mifamurtide is a treatment for children, adolescents and young adults with a rare type of bone cancer, osteosarcoma.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Jakavi (rare bone marrow disorder); Signifor (Cushing's disease) plus 16 products in 24 pivotal trials. . ... Additional revenues for these two drugs are also promised in other cancer types not to mention their “combo” potential.

  • The distressing impact of rare diseases The distressing impact of rare diseases

    A US patient with Multiple Hereditary Exostosis (that can cause bone cancer) quoted in the report said: “Finding a doctor that can treat me is the most difficult part.

  • Pharma deals during November 2013 Pharma deals during November 2013

    Hot on the heels of the European approval of Xofiga (an innovative radiotherapeutic for bone metastases in prostate cancer) reported on November 18, Bayer's opening offer for the Norwegian company. ... It is in clinical development for treating FGF

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....